Ad is loading...
FTRE
Price
$19.34
Change
-$0.86 (-4.26%)
Updated
Nov 15 closing price
RVNC
Price
$4.17
Change
-$0.14 (-3.25%)
Updated
Nov 15 closing price
107 days until earnings call
Ad is loading...

FTRE vs RVNC

Header iconFTRE vs RVNC Comparison
Open Charts FTRE vs RVNCBanner chart's image
Fortrea Holdings
Price$19.34
Change-$0.86 (-4.26%)
Volume$1.59M
CapitalizationN/A
Revance Therapeutics
Price$4.17
Change-$0.14 (-3.25%)
Volume$1.21M
CapitalizationN/A
FTRE vs RVNC Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
FTRE vs. RVNC commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Sell and RVNC is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (FTRE: $19.34 vs. RVNC: $4.17)
Brand notoriety: FTRE and RVNC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 96% vs. RVNC: 38%
Market capitalization -- FTRE: $1.73B vs. RVNC: $437.44M
FTRE [@Biotechnology] is valued at $1.73B. RVNC’s [@Biotechnology] market capitalization is $437.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileRVNC’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • RVNC’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than RVNC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 4 TA indicator(s) are bullish while RVNC’s TA Score has 4 bullish TA indicator(s).

  • FTRE’s TA Score: 4 bullish, 6 bearish.
  • RVNC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both FTRE and RVNC are a bad buy in the short-term.

Price Growth

FTRE (@Biotechnology) experienced а -17.70% price change this week, while RVNC (@Biotechnology) price change was +12.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

FTRE is expected to report earnings on Nov 08, 2024.

RVNC is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.74B) has a higher market cap than RVNC($437M). FTRE YTD gains are higher at: -44.585 vs. RVNC (-52.560). FTRE has higher annual earnings (EBITDA): 34.8M vs. RVNC (-274.04M). RVNC has more cash in the bank: 232M vs. FTRE (126M). RVNC has less debt than FTRE: RVNC (492M) vs FTRE (1.2B). FTRE has higher revenues than RVNC: FTRE (3.02B) vs RVNC (251M).
FTRERVNCFTRE / RVNC
Capitalization1.74B437M397%
EBITDA34.8M-274.04M-13%
Gain YTD-44.585-52.56085%
P/E RatioN/AN/A-
Revenue3.02B251M1,201%
Total Cash126M232M54%
Total Debt1.2B492M245%
FUNDAMENTALS RATINGS
RVNC: Fundamental Ratings
RVNC
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTRERVNC
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
68%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMSX8.09N/A
N/A
Nuveen Emerging Markets Eq Retiremt
IGNIX17.25-0.05
-0.29%
Delaware Ivy Natural Resources I
FCLTX47.66-0.27
-0.56%
Fidelity Advisor Industrials M
LVAMX12.28-0.08
-0.65%
LSV US Managed Volatility Investor
UCNQX49.58-1.22
-2.40%
Victory Nasdaq 100 Index C

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with VCEL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then VCEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-4.26%
VCEL - FTRE
34%
Loosely correlated
-0.49%
RVNC - FTRE
34%
Loosely correlated
-3.25%
QSI - FTRE
33%
Loosely correlated
-5.77%
AURA - FTRE
32%
Poorly correlated
-5.02%
ORIC - FTRE
32%
Poorly correlated
-3.74%
More

RVNC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVNC has been loosely correlated with AXON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RVNC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVNC
1D Price
Change %
RVNC100%
-3.25%
AXON - RVNC
39%
Loosely correlated
-0.86%
HRMY - RVNC
39%
Loosely correlated
+0.65%
ABCL - RVNC
37%
Loosely correlated
-3.99%
GOSS - RVNC
35%
Loosely correlated
-3.88%
NTLA - RVNC
34%
Loosely correlated
-7.61%
More